arrow
A

Andrew J. Gifford

children's cancer institute
H指数:32
被引数:6,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Precision-guided therapy in H3K27-altered diffuse midline glioma

H3K27-改变的弥漫性中线胶质瘤中的精准导向疗法

2026-05-190
OAAI
P-glycoprotein as a chemotherapy resistance mechanism and biomarker of poor response in high-risk neuroblastoma
2025-11-010
OA
High-throughput 3D engineered paediatric tumour models for precision medicine

高通量3D工程化儿科肿瘤模型用于精准医学

2025-10-010
OAAI
Returning raw genomic data to research participants in a pediatric cancer precision medicine trial (vol 10, 12, 2025)

在儿科癌症精准医学试验(第10卷,第12期,2025年)中向研究参与者返还原始基因组数据

2025-03-240
OA
The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia

CD123抗体药物偶联物pivekimab sunirine在儿童急性淋巴细胞白血病临床前模型中表现出显著的活性。

2025-01-171
OAAI
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia
2024-11-060
OAAI
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis

高尔基体定位的环指蛋白121是MYCN驱动的神经母细胞瘤肿瘤发生所必需的

2024-10-140
OAAI
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis

转录共阻遏物Runx1t1对于MYCN驱动的神经母细胞瘤肿瘤发生至关重要

2024-07-111
OAAI
PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
2024-06-180
OAAI
Precision-guided treatment in high-risk pediatric cancers
2024-06-067
OAAI
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

原发性肿瘤细胞的高通量药物筛选确定治疗高危癌症儿童的治疗策略

2023-07-3114
OAAI
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
2023-06-237
OA
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer

一种新的转录特征识别高危儿科癌症中的T细胞浸润

2023-04-033
OAAI
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes

H3K27me3缺失的组蛋白H3-wild型弥漫性中线胶质瘤是一个独特的实体,具有EGFR或ACVR1突变和同源框基因的差异甲基化

2023-03-077
OAAI
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma
2022-11-1710
OA
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

肿瘤细胞的体外和体内药物筛选确定高危儿童癌症的新疗法

2021-12-2019
OAAI
Neuro-Oncology Advances
2021-08-255
OAAI